Chromocell Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Feb 24 | BuyUS$100,002 | Ezra Friedberg | Individual | 16,667 | US$6.00 |
Insider Trading Volume
Insider Buying: CHRO insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 574,878 | 9.78% |
General Public | 884,815 | 15.1% |
Individual Insiders | 1,204,040 | 20.5% |
Private Companies | 3,214,102 | 54.7% |
Dilution of Shares: CHRO only recently listed within the past 12 months
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,041,438 | US$2.1m | -2.34% | no data | |||
747,187 | US$1.5m | -31.7% | no data | |||
483,406 | US$971.6k | 2.71% | no data | |||
471,592 | US$947.9k | 0% | no data | |||
443,071 | US$890.6k | 3.87% | no data | |||
384,226 | US$772.3k | 0% | no data | |||
369,178 | US$742.0k | 5.13% | no data | |||
318,823 | US$640.8k | 0% | 44.38% | |||
273,776 | US$550.3k | 0% | no data | |||
251,888 | US$506.3k | 0% | 0.08% | |||
130,953 | US$263.2k | 0% | no data | |||
41,666 | US$83.7k | 0% | no data | |||
29,167 | US$58.6k | 0% | no data | |||
4,167 | US$8.4k | 0% | 32.44% | |||
2,482 | US$5.0k | 0% | no data |